Preparation and evaluation of polyamidoamine dendrimer (G2)/branched-β-cyclodextrin conjugate as a novel gene transfer carrier
Authors:
- 24 September 2010
- journal article
- research article
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 70 (3-4) , 339-344
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In Vitro and In Vivo gene delivery mediated by Lactosylated Dendrimer/α-Cyclodextrin Conjugates (G2) into HepatocytesJournal of Controlled Release, 2010
- Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNASensors, 2009
- Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA)Journal of Controlled Release, 2007
- Cyclodextrin-based pharmaceutics: past, present and futureNature Reviews Drug Discovery, 2004
- 6-O-α-(4-O-α-d-glucuronyl)-d-glucosyl-β-cyclodextrin: solubilizing ability and some cellular effectsInternational Journal of Pharmaceutics, 2002
- Effects of Structure of Polyamidoamine Dendrimer on Gene Transfer Efficiency of the Dendrimer Conjugate with α-CyclodextrinBioconjugate Chemistry, 2002
- Enhancement of Gene Expression by Polyamidoamine Dendrimer Conjugates with α-, β-, and γ-CyclodextrinsBioconjugate Chemistry, 2001
- Substituted β-Cyclodextrins Interact with PAMAM Dendrimer–DNA Complexes and Modify Transfection EfficiencyBiochemical and Biophysical Research Communications, 2001
- Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequenceArchives of Virology, 1997
- Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety EvaluationJournal of Pharmaceutical Sciences, 1997